News
Kyrsten Sinema unloaded $3 million of her former campaign funds to help Arizona State University research artificial ...
Sinema, a Democrat-turned-independent, was a professor at ASU for over 20 years. She said she intends for the university to ...
Former Sen. Kyrsten Sinema is advocating for an Arizona bill that would fund clinical trials on ibogaine, a psychedelic currently listed as a Schedule 1 drug. Sinema recently joined Hogan Lovells ...
WASHINGTON, April 2 (Reuters) - A pair of top Democratic lawmakers asked the U.S. securities regulator on Wednesday to preserve records related to President Donald Trump’s crypto venture World ...
18d
LGBTQ Nation on MSNKyrsten Sinema left the Senate & lands at a lobbying firmWashington’s revolving door between lawmakers and its lobbying class saw former Sen. Kyrsten Sinema (I-AZ) emerge with a new job on Monday. The onetime Democrat, attorney, and the first out bisexual ...
Former Sen. Kyrsten Sinema has a new role at the law firm Hogan Lovells, where she’ll use her experience as a Capitol Hill ...
The crypto market’s recovery today aligns closely with similar rebounds in the US stock market, ahead of Trump’s “liberation day,” with Bitcoin leading the market higher. What you should ...
31,170 people played the daily Crossword recently. Can you solve it faster than others?31,170 people played the daily Crossword recently. Can you solve it faster than others?
Former Arizona Senator Kyrsten Sinema is joining Hogan Lovells’ DC office, the firm announced Monday. Sinema plans to help clients shape regulations, navigate risk and protect business interests at ...
March 31 (Reuters) - Former Independent U.S. Senator Kyrsten Sinema of Arizona is joining ... In January, she joined crypto exchange Coinbase's global advisory council. Hogan Lovells has ...
TOKYO, March 30 (Reuters) - Japan's Financial Services Agency (FSA) plans to revise the Financial Instruments and Exchange Act to give crypto assets a legal status as financial products ...
CoreWeave began trading on Friday with more of a shrug than a war cry. The company priced at $40 on Thursday, below the $47 to $50 price range announced. It also trimmed the number of shares offered.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results